<DOC>
	<DOCNO>NCT00432978</DOCNO>
	<brief_summary>This study determine whether bosentan alter exercise capacity rapid ascent high altitude . We hypothesize bosentan administration improve arterial oxygenation exercise capacity .</brief_summary>
	<brief_title>Effect Bosentan Exercise Capacity High Altitude</brief_title>
	<detailed_description>Both prostacyclin nitric oxide pathway important modulate hypoxic pulmonary vasoconstriction ( HPV ) . There little information role endothelin pathway high altitude . The endothelin pathway involve activation two distinct receptor , A B. Bosentan nonpeptide , specific , competitive , dual antagonist endothelin receptor subtypes . The primary objective study determine effect endothelin receptor blockade bosentan exercise performance HPV . This prospective , double blind , placebo-controlled , randomize cross-over study involve healthy subject age 25-55 year age . Subjects undergo echocardiography exercise test low altitude ( &lt; 500m ) 3800m . Subjects receive either bosentan vs. placebo study low high altitude two occasion crossover design . Primary outcome measure pulmonary artery systolic pressure measure echo-Doppler exercise capacity . A good understanding role endothelin pathway HPV may lead improved treatment patient .</detailed_description>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Bosentan</mesh_term>
	<criteria>Normal healthy subject age 18 55 year Pregnancy Heart , lung liver disease Use glyburide , cyclosporin A</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>hypoxia</keyword>
	<keyword>endothelin</keyword>
	<keyword>exercise</keyword>
</DOC>